Annual ROE
-31.42%
-11.91%-61.05%
December 31, 2023
Summary
- As of February 7, 2025, EWTX annual return on equity is -31.42%, with the most recent change of -11.91% (-61.05%) on December 31, 2023.
- During the last 3 years, EWTX annual ROE has fallen by -82.66% (-161.32%).
- EWTX annual ROE is now -154.56% below its all-time high of 57.59%, reached on December 31, 2019.
Performance
EWTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-26.83%
+1.18%+4.21%
September 30, 2024
Summary
- As of February 7, 2025, EWTX quarterly return on equity is -26.83%, with the most recent change of +1.18% (+4.21%) on September 30, 2024.
- Over the past year, EWTX quarterly ROE has increased by +1.17% (+4.18%).
- EWTX quarterly ROE is now -152.36% below its all-time high of 51.24%, reached on December 31, 2020.
Performance
EWTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
EWTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.0% | +4.2% |
| 3 y3 years | -161.3% | +4.2% |
| 5 y5 years | -154.6% | +4.2% |
EWTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -101.4% | at low | -82.2% | +16.3% |
| 5 y | 5-year | -154.6% | at low | -152.4% | +16.3% |
| alltime | all time | -154.6% | at low | -152.4% | +16.3% |
Edgewise Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -26.83%(-4.2%) |
| Jun 2024 | - | -28.01%(-3.7%) |
| Mar 2024 | - | -29.09%(-9.3%) |
| Dec 2023 | -31.42%(+61.0%) | -32.06%(+14.5%) |
| Sep 2023 | - | -28.00%(+16.2%) |
| Jun 2023 | - | -24.09%(+1.9%) |
| Mar 2023 | - | -23.63%(+6.1%) |
| Dec 2022 | -19.51% | -22.27%(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -21.33%(+0.9%) |
| Jun 2022 | - | -21.14%(+16.5%) |
| Mar 2022 | - | -18.14%(+23.2%) |
| Dec 2021 | -15.60%(-130.4%) | -14.73%(-13.6%) |
| Sep 2021 | - | -17.05%(+19.2%) |
| Jun 2021 | - | -14.30%(-6.0%) |
| Mar 2021 | - | -15.21%(-129.7%) |
| Dec 2020 | 51.24%(-11.0%) | 51.24% |
| Dec 2019 | 57.59% | - |
FAQ
- What is Edgewise Therapeutics annual return on equity?
- What is the all time high annual ROE for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual ROE year-on-year change?
- What is Edgewise Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly ROE year-on-year change?
What is Edgewise Therapeutics annual return on equity?
The current annual ROE of EWTX is -31.42%
What is the all time high annual ROE for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual return on equity is 57.59%
What is Edgewise Therapeutics annual ROE year-on-year change?
Over the past year, EWTX annual return on equity has changed by -11.91% (-61.05%)
What is Edgewise Therapeutics quarterly return on equity?
The current quarterly ROE of EWTX is -26.83%
What is the all time high quarterly ROE for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly return on equity is 51.24%
What is Edgewise Therapeutics quarterly ROE year-on-year change?
Over the past year, EWTX quarterly return on equity has changed by +1.17% (+4.18%)